Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

1
Player Avatar JohnyRay (80.39) Submitted: 9/11/2006 12:47:50 AM : Outperform Start Price: $16.40 BMY Score: +152.08

Great dividend, nice pipeline, but uncertain short-term prospects. Really bad management but hopefully that will change.

Featured Broker Partners


Advertisement